Home » CGT CDMO

Cell and Gene Therapy Services

Cell and Gene Therapy

Cell and Gene Therapy Services

Cell and gene therapy (CGT) has the potential to transform medicine, providing long term and potentially curative treatment options for a wide range of diseases. GenScript develops GMP platform to provide vectors, including viral vectors and non-viral vectors. Following the new drug development process, plasmid and virus in different quality levels are provided to meet requirements in different stages with rapid turn-around time.

Vector manufacturing service along with the CGT development

LentiHelper^TM Plasmid

AAssistV^TM Plasmid

Plasmid CDMO

Lentiviral Vector CDMO

AAV CDMO

mRNA CDMO

Preclinical

IND Filing

Phase I

Phase II

Phase III

BLA/NDA

Commercial

gct-overview

GMPro^TM Plasmid

Pro Lentiviral
Vector

Lentiviral
Vector CMC

Clinical GMP Lentiviral
Vector

GMP Lentiviral Vector

GMP Lentiviral Vector

Clinical GMP AAV Vector

GMP AAV Vector

PC/PV

GMP AAV Vector

PC/PV

Service Category